Boehringer Ingelheim’s COPD and asthma inhalers are now …

Ridgefield, Conn., June 1, 2024 – Boehringer Ingelheim’s new program to cap out-of-pocket costs at $35 per month for eligible patients i for the company’s inhalers is now available. With this …

$35
OFF

Boehringer Ingelheim’s COPD And Asthma Inhalers Are Now …

4 weeks from now

boehringer-ingelheim.com

$35
OFF

BRIEF—Boehringer COPD And Asthma Inhalers Now Available For …

4 weeks from now

Jun 1, 2024 · German family-owned pharma major Boehringer Ingelheim’s new program to cap out-of-pocket costs at $35 per month for eligible patients for the company’s inhalers is now …

thepharmaletter.com

$35
OFF

Boehringer Ingelheim Inhaler Cost Cap Program Launches - Drug …

4 weeks from now

Jun 3, 2024 · A first of its kind program from Boehringer Ingelheim capping the cost of inhalers for chronic obstructive pulmonary disease (COPD) and asthma at $35 launched on June 1, 2024. …

drugtopics.com

$35
OFF

Boehringer Ingelheim's COPD And Asthma Inhalers Are Now …

4 weeks from now

Jun 1, 2024 · Boehringer Ingelheim's new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company's inhalers is now available. With this program, patients …

yahoo.com

$35
OFF

Boehringer Ingelheim Caps Asthma, COPD Inhalers At $35 Per …

4 weeks from now

Jun 5, 2024 · Out-of-pocket costs for Boehringer Ingelheim asthma and chronic obstructive pulmonary disease (COPD) inhalers will be capped at $35 per month for eligible patients, …

pulmonologyadvisor.com

$35
OFF

These Inhalers No Longer Cost More Than $35 Per Month

4 weeks from now

Mar 26, 2024 · Jean-Michel Boers, president and CEO of Boehringer Ingelheim USA Corporation, said in a statement that the company wants “to do our part to help patients living with COPD or …

verywellhealth.com

$35
OFF

Boehringer Ingelheim's COPD And Asthma Inhalers Are Now

4 weeks from now

Jun 1, 2024 · Boehringer Ingelheim’s new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company’s inhalers is now available. Boehringer’s first-of-its-kind …

biospace.com

FAQs about Boehringer Ingelheim’s COPD and asthma inhalers are now … Coupon?

Does Boehringer Ingelheim cap out-of-pocket costs?

RIDGEFIELD, Conn., June 1, 2024 /PRNewswire/ -- Boehringer Ingelheim's new program to cap out-of-pocket costs at $35 per month for eligible patients i for the company's inhalers is now available. With this program, patients who have had difficulty navigating the current healthcare system will now be able to afford the Boehringer inhalers they need. ...

Can you afford Boehringer inhalers?

With this program, patients who have had difficulty navigating the current healthcare system will now be able to afford the Boehringer inhalers they need. “Ensuring equitable access to life-saving medications is not just a commitment—it’s our responsibility,” said Jean-Michel Boers, President and CEO, Boehringer Ingelheim USA Corporation. ...

Is Boehringer Ingelheim a reusable inhaler?

Boehringer Ingelheim The first reusable, propellant-free inhaler is now available for patients with asthma and COPD, in line with NHS plans to reduce its carbon footprint and plastic waste. ...

Are inhalers a 'great news' for people with chronic obstructive pulmonary disease (COPD)?

Purvi Parikh, MD, an allergist with Allergy & Asthma Network, told Verywell Health that this is "great news" for people with asthma and chronic obstructive pulmonary disease (COPD). “Many patients, including my own, cannot afford their inhalers despite having health insurance due to exorbitant costs,” Parikh said. ...

Can a reusable inhaler help patients with asthma and COPD?

The first reusable, propellant-free inhaler is now available for patients with asthma and COPD, in line with NHS plans to reduce its carbon footprint and plastic waste Boehringer Ingelheim ...

Are pharmaceutical companies capping out-of-pocket inhalers at $35?

Amidst untenable drug prices, there's finally some good news: Several pharmaceutical companies are capping the out-of-pocket price of select inhalers at $35. GlaxoSmithKline (GSK) is the latest company to announce a price cap this month, following the lead of AstraZeneca and Boehringer Ingelheim, who revealed their inhaler price ceilings in March. ...